Der er begrænset erfaringen med patienter, som er alvorligt immunkompromitteret, er i immunsuppressiv behandling og patienter med alvorlig neutropeni, idet disse patienter var ekskluderet i fase 3 forsøgene.
The experience in patients who are severely immunocompromised, receiving immunosuppressive therapy, and patients with severe neutropenia is limited since this population was excluded from phase 3 trials.